FT : Brazil’s ‘first ethanol billionaire’ hits at petrol price curbs

Brazil’s ‘first ethanol billionaire’ hits at petrol price curbs

Rubens Ometto, the sugar cane tycoon, has described government petrol price controls as a “disaster”, in a rare outburst for Brazil’s normally reserved business community.
The chief executive of Cosan, the sugar and logistics company, ratcheted up the pressure on President Dilma Rousseff’s government, which is already unpopular with markets, by telling a gathering of Brazil’s business elite that the government needed to “get off the backs of entrepreneurs”.

Mr Ometto, described by Forbes magazine as the first ethanol billionaire, said the government’s price controls for state-owned oil company Petrobras were destroying the country’s prized ethanol industry. Petrobras is being forced to import petrol at international prices and sell it domestically at a discount to help control inflation, meaning ethanol producers have to compete with subsidised gasoline.
“If this policy has for us [ethanol producers] been ruinous, it has been fatal for Petrobras,” Mr Ometto said at a Brazilian American Chamber of Commerce awards dinner in New York late last week, at which he was honoured for his contribution to Brazilian business.
Ms Rousseff’s government holds a strong lead heading into elections scheduled for October, but she has been falling in opinion polls. Each dip in her popularity has helped drive a rally in the country’s stock market as investors bet that a victory for the opposition or a weakening of the president in her second term could lead to more business-friendly policies.
Aside from the petrol price controls, investors point to the government’s intervention in electrical energy prices, its maintenance of a minimum wage policy not linked to productivity and its previous meddling in currency markets as destructive for the investment climate.
“This [petrol price policy] is a disaster because businessmen cannot plan,” Mr Ometto told the FT. “It is one thing if you plan a business and you commit an error in your projections and diagnoses; it’s another thing if you are penalised because the rules change in the middle of it.”
Mr Ometto’s outspoken comments were unusual in a business community that generally keeps very close ties with government. While big Brazilian companies tend to be well managed, the government’s central place in the economy, given its sheer size, means most rely on it for some business.
BNDES, Brazil’s development bank, is also the main source of long-term lending in the economy, with big business dependent on its allocations of loans at cheaper rates than those available from private-sector banks.
In his speech to the awards dinner – whose attendees included Luciano Coutinho, the head of the BNDES – Mr Ometto called on the government to lift burdens such as a convoluted taxation system and difficult labour laws.
If the government could not help, it could “at least not get in the way”, Mr Ometto said.
His company, Cosan, is also a partner of Anglo-Dutch group Shell.

WSJ : China to Permit Some Provinces and Cities to Sell Bonds on Own Credit

China to Permit Some Provinces and Cities to Sell Bonds on Own Credit
Market Likely to Be Tapped in July

China will allow 10 provinces and cities to sell bonds on their own credit later this year, introducing the country's first Western-style municipal bonds as it broadens the financial choices for local governments.

The list will cover six provinces, including the wealthy eastern Zhejiang, Jiangsu and Shandong, southern Guangdong and two less-developed provinces in central and western China. The four cities are Beijing, Shanghai, Shenzhen and another city on the country's eastern coast, said a person familiar with the situation.

The central government will announce the plan later this month and bonds will likely be issued in early July, the person said.

Local governments are generally barred from directly issuing debt because of concerns over rising debt and fears that some local administrations don't have the ability to manage their own funds.

China began issuing local-government bonds in 2009 to offer local authorities more financing channels. The finance ministry sold all such bonds on behalf of the local authorities in 2009 and 2010.

Beijing started a trial program in late 2011 to allow a few provinces and cities to sell bonds directly, a potential first step toward putting local-government finances in order. But the bonds were still supported by the central government, because the finance ministry continued to repay the principal and interest on the local authorities' behalf.

The new municipal bonds will be rated and investors will probably ask for higher yields because the local authorities will repay the debt themselves.

China is revising its budget law to give such bond offers formal permission. The most-recent draft of the law, which still needs legislative approval, includes a provision for local governments to issue bonds directly to fund essential projects.

It is unclear how much debt the 10 provinces and cities will offer this year, but Beijing has raised the total local-government bond quota to 400 billion yuan ($64.2 billion) this year, up from 350 billion yuan in 2013, according to the country's deficit plan for 2014. China announced a larger budget deficit this year as it tries to overhaul the economy and respond to the effects of slower growth.

The finance ministry has asked local governments to make proper use of the bond proceeds, with increased support for social welfare and economic restructuring, the Xinhua news agency said earlier.

China's National Audit Office said in late 2013 that debt and guarantees issued by local governments had surged 67% to 17.9 trillion yuan by the end of June 2013, compared with the last tally of local debt at the end of 2010 of 10.7 trillion yuan.

In response to the 2008 financial crisis, many local governments in China undertook major spending projects to stimulate economic growth. Much of this was financed through special investment platforms set up specifically to skirt rules barring local governments from borrowing directly from financial institutions.

That has led to greater scrutiny from Beijing of local-government financing policies, although it has tried to balance that by opening the doors to governments that prove they can manage their finances successfully.

WSJ : Pfizer Said to Be Planning to Make Sweetened Bid for AstraZeneca

Pfizer Said to Be Planning to Make Sweetened Bid for AstraZeneca

Pfizer May Walk Away From Deal if Latest Bid Rejected

Pfizer Inc. PFE +0.21% was planning to make a sweetened takeover offer for AstraZeneca AZN.LN +2.05% PLC on Sunday, according to people familiar with the matter, in a last-ditch effort to bring the U.K. drug giant to the negotiating table.

Pfizer, which has already been rebuffed by AstraZeneca more than once, may walk away from its proposed deal if the latest advance is turned away, the people said.

Details of a new offer, and where any talks between the two companies currently stand, couldn't be discerned.

Pfizer first approached AstraZeneca late last year about a trans-Atlantic tie-up between the companies that would rank as one of the healthcare industry's biggest ever. The U.S. pharmaceutical company's most recent offer, worth about $106 billion and consisting mainly of its own stock, was made at the beginning of this month and quickly rejected by AstraZeneca's board.

>>> General Electric drops out of bidding for Ansaldo STS

General Electric drops out of bidding for Ansaldo STS 

General Electric, the US-listed, Connecticut-based conglomerate, has dropped out of the bidding for Ansaldo STS, the listed, Italian manufacturer of railway signaling equipment.

According to Italian-language daily Il Sole 24 Ore's report, which cited financial sources, GE could have made the move to focus on its bid for listed, French, defence group Alstom. However, the article added that GE could rejoin the bidding at a later stage.

The item said that the Japanese conglomerate Hitachi is also believed to have pulled out.

The report also claimed that the sale of Ansaldo STS and rolling stock manufacturer Ansaldo Breda by listed, Italian, defence group Finmeccanica has been stalled currently due to the replacement of Alessandro Pansa as CEO by Mauro Moretti. However, the item said that the sales process is likely to resume shortly.

The report said that French defence group Thales and Canadian rolling stock manufacturer Bombardier are now believed to be the two keenest suitors for Ansaldo STS and Ansaldo Breda. The item added that Chinese groups CNR Corporation and Insigma are also believed to be interested in the two units.


Source Il Sole 24 Ore

NY Post : Despite the news, the economy is still a zero

Is the US in a recession?
No, according to the traditional definition of two negative quarters of gross domestic product.
But to a middle-class family and those less fortunate, a couple of GDP ticks up or down are utterly meaningless.
In Washington — where the learned economists who came up with the definition toil — not a single pencil-pusher saw the massive 2007-2009 financial crisis coming or the fact that the economy would not grow in the first quarter of this year.
In fact, at the Fed they forecast 2 percent growth for the quarter.
Let’s move to the kitchen table, where the real-life economic decisions get made. What bills will be paid and what purchases can be made?
This is where economic growth begins — and where barely any of the $4 trillion of the Fed’s ballooning balance sheet has reached.
Walmart reported earnings Thursday, and they are a meaningful measure of what’s going on in the consumer’s kitchen.
With its vast array of products, Walmart is America’s general store. It provides a window on not only how much consumers spend, but also what they’re spending it on every day.
So when Walmart guided down estimates for next quarter, stocks and bonds became even more fearful of growing economic weakness.
When in doubt, look to the bond market — the adult in the room — for guidance in these important matters.
The 10-year Treasury bond yield is trading at recessionary levels. The benchmark note broke below the psychologically important level of 2.5 percent, and the 30-year is at 3.33 percent.
Besides being a gauge for mortgage rates, these yields say that Treasury market traders don’t see much growth — if any — for the near future.
Speaking of kitchens, for most Americans, President Harry S. Truman’s famous quote works quite well for defining an economic slowdown: “It’s a recession when your neighbor loses his job; it’s a depression when you lose yours.”
Today everybody has a friend or family member out of work. No matter how the Beltway economists slice it or how they spin it, this zero of an economy is still at zero.

FT : Pfizer poised to sweeten offer for AstraZeneca

Pfizer poised to sweeten offer for AstraZeneca

The Pfizer Inc. company logo, right, and the AstraZeneca Plc company logo, are seen on boxes of pharmaceutical products produced by the drug makers in this arranged photograph taken in London, U.K., on Friday, May 2, 2014. AstraZeneca Plc rejected Pfizer Inc.'s sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to recognize the value of the promising experimental medicines under development by the U.K.'s second-biggest drugmaker. Photographer: Chris Ratcliffe/Bloomberg©Bloomberg
AstraZeneca is braced for a fresh approach from Pfizer as the UK government holds talks with Brussels about its options for intervening in what would be the biggest foreign takeover of a British company.
Pfizer was weighing its next move over the weekend as the clock ticked towards the May 26 deadline for the US drugmaker to sweeten its £63bn offer or walk away under UK takeover rules.

People close to both companies said they expected Pfizer, maker of the Lipitor cholesterol treatment and Viagra anti-impotence pill, to improve on the £50-per-share proposal rebuffed by AstraZeneca earlier this month.
Big shareholders and analysts have said an offer between £53 and £55 per share is likely to be needed to bring AstraZeneca to the table, with a higher portion of cash than the two-thirds paper proposal made on May 2.
Pfizer has not ruled out making a hostile bid but people close to the US company say it still hopes to persuade its UK rival to enter talks over a friendly deal.
People close to AstraZeneca said on Sunday that, while the UK-listed drugmaker would consider a higher offer, it continued to believe the company was best off independent.
Meanwhile, UK government officials have held informal early-stage discussions with the European Commission to establish what powers the UK would have should ministers attempt to intervene, according to people familiar with the talks.
David Cameron is under pressure from the opposition Labour party to subject any deal to a “public interest test” amid concerns over what impact a US takeover of AstraZeneca would mean for Britain’s life sciences sector.
While the prime minister has made clear his reluctance to do anything that undermines the UK’s reputation for openness to foreign investment, he has given the go-ahead for officials to explore the government’s options.
Under EU law, ministers can intervene in big mergers on public interest grounds but ultimately the move needs approval from Brussels. Three reasons to intervene are specifically mentioned in EU regulations: public security, media plurality and financial stability.
The UK has in the past intervened in a water merger citing public security concerns and officials are taking advice on whether it could do the same in the pharmaceuticals sector.
An alternative is to ask Brussels for permission to intervene on other grounds, such as protecting the R&D base. The commission, which has the job of guarding against protectionism, has never accepted such a request and people familiar with the process say the bar is “very high”.
British officials are examining whether legally binding commitments from Pfizer on research and investment could be attached to merger approval from the commission.
Ministers are not yet involved in any discussions with Brussels. Vince Cable, business secretary, told MPs last week that the “mere fact that the government would enter into a conversation with the commission is potentially highly significant in terms of the bid and its effect on the shareholders”.
Business leaders have warned ministers against any move that creates the impression the UK is resorting to “protectionism”.
Katja Hall, the CBI’s new deputy director-general, said executives wanted the government to protect Britain’s science base but were nervous about Labour’s more hardline position. “We’ve got to make sure that any commitments [from Pfizer] are made to stick,” Ms Hall said. “But the concern is if there is any impression given that the UK wasn’t open for business.
“The UK has always been a trading nation and ultimately we will be successful by being able to export goods and services to other parts of the world and by making sure we get investment into the UK. We mustn’t resort to protectionism.”

FT : Telecoms watchdog warns on EU rules

Telecoms watchdog warns on EU rules
The British telecoms regulator has warned that proposed European rules safeguarding “net neutrality” could be damaging if they fail to recognise the need for internet management.
Last month, the European Commission agreed proposals to ensure “net neutrality”, the concept of unrestricted access to the internet. The plans would, for example, ban “business class” internet access for companies willing to pay more.

But support for a more flexible approach to internet management has emerged from the UK, where the regulator Ofcom has said that “well-intentioned but overprescriptive and detailed legislation may deliver the opposite of the intended effect”.
In a speech, Ed Richards, chief executive of Ofcom, expressed concern that such legislation would mean “not more certainty but less. Not the timely exercise of reasonable objective judgment, but the pursuit of time-consuming and self-interested litigation”.
Mr Richards has, as an alternative, outlined a view on legislation that allows both sustaining the quality and performance of the internet and the provision of managed services.
He said that blocking of any kind by internet access providers was “highly undesirable” but that companies should be allowed to apply traffic management to optimise the consumer experience.
He said: “This should not extend to outright blocking, throttling or practices such as the anti-competitive prioritisation of a network’s own content and services. However, it is important that framework of regulation should be fully capable of addressing areas of serious concern such as child safety.”
Mr Richards also supported the provision of managed services by network operators to help them make “a return for investment they have made in their networks” – adding that this should ultimately be beneficial for consumer.
His words are likely to be welcomed by companies in the telecoms industry, which want to develop specialised services and charge different prices.
Telecoms executives have also said that the rules failed to recognise the need to manage internet traffic in order to ensure that services are not degraded. However, the sector has less benevolent reasons to complain given internet services such as WhatsApp and Skype have seen their revenues hit by rival free services.
EU member states will be able to tweak the net neutrality law, although most are expected broadly to support the package that also includes proposals on cutting roaming charges.
The Department for Culture, Media and Sports said that the UK government supported a flexible approach.
“We are committed to an open, safe and secure internet that allows growth and innovation, delivering services and products that consumers want,” it said. “However, we believe that self-regulation and greater transparency of traffic management measures would be more effective ... Regulation risks being too prescriptive, inflexible and may have unintended consequences.”

>>> Barrons summary: positive on AMTD, PBI; cautious on AVP

Barrons summary: positive on AMTD, PBI; cautious on AVP

Cover story: Profile of Jana Partners Barry Rosenstein, whose Jana Nirvana fund has had a three-year annualized gain of 19.1%, topping the 16% return of the S&P 500 since the end of 2013 (+ WAG, OIS, EQIX); Barrons list of the Top 100 Hedge Funds, led by Glenview Offshore Opportunity, Hildene Opportunities LP, Chenavari-Toro Capital IA Class A, Childrens Investment Ltd., and Tiger Global. 

Features: Cautious on AVP: Company is doing well under turnaround led by CEO Sheri McCoy, and bulls argue shares could return to the low $20s in a couple of years, but key to success hinges on fixing North American operations; Positive on AMTD: Improving trading volumes could help shares appreciate by 35%, while rising interest rates could give entire sector a boost; Positive on PBI: Under CEO Marc Lautenbach the companys postage-meter business has stabilized and become profitable, while new digital businesses will continue to drive growth that could boost shares 60% in the next three years. 

Tech Trader: Cautious on CSCO: Despite beating expectations for fiscal third quarter, company still faces a major threat from software-defined networking, in which its equipment can be replaced by something like a general-purpose computer running switching software; Cautious on FB, AMZN: Tiernan Ray continues to question the metrics being used by analysts to trumpet shares of tech giants. 

Trader: Despite index highs, says Michael Marrale of ITC, theres an incredible amount of pessimism and negativity in equity markets; Cautious on TGI: Aerospace structure business is companys problem child, but if it can fix that, slowing growth may stabilize and it may win more contracts such as a recent one from Airbus; Negative on WWE: Stock price contains a lot, but not all, of the recent bad news for company that has overestimated its ability to attract new viewers. 

Follow-Up: Cautious on PFE: Pharma giant should stop pursuit of AZN, since deal doesnt make sense strategically and would shackle company to what is probably the worst-positioned major global drug company based on projected revenues and profits in the coming years; Cautious on R: Shares have outperformed the broader market, but at their current price the stocks valuation has caught up with its growth prospects. 

Mutual Funds: Interview with Andy Acker, Manager, Janus Global Life Sciences (top ten holdings: GILD, AET, ESRX, JNJ, CELG, BIIB, Roche Holding, VRX, AZN, NPSP). 

European Trader: Positive on Bankia: Spains so-called bad bank could be about to come good for investors, with shares climbing 20% in the next 12 months as management overhaul provides a solid foundation for future growth. 

Asian Trader: Positive on Softbank: Investors looking for a way to play Alibaba are better off with telecommunications giant than with YHOO, and its $57 possible profit on Alibaba IPO could set a record. 

Emerging Markets: Li Ka-shing, Asias richest man, has been selling Chinese real estate stocks, including large holdings in tier-one cities such as Shanghai and Guangzhou; for small investors, only those willing to wait for a correction should venture into the sector. 

Commodities: After two years of decline, titanium prices appear to have reached rock bottom. CEO Spotlight: Profile of KKRs Henry Kravis and George Roberts, who say if they were starting their firm today they would focus on smaller real-estate deals, not private equity. 

Streetwise: GS strategist David Kostin screened for companies that have spent less on capex relative to sales during they past five years than they did during the previous five (Positive on COP, SHW, ORCL); Some sectors are seeing capital spending opportunities that are simply too good to pass up.